Fri, Mar 29, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

AIMA calls for deeper global coordination of OTC derivatives regulation

Tuesday, May 28, 2013
Opalesque Industry Update - The Alternative Investment Management Association (AIMA), the global hedge fund industry association, has produced a paper that highlights the key areas where deeper coordination of over-the-counter (OTC) derivatives regulation is required to achieve the G20 objective of maintaining global markets.

The paper, ‘Addressing overlaps between EMIR and CFTC OTC derivatives regulation’, provides examples of potential regulatory conflicts or unnecessary overlap between the European Markets Infrastructure Regulation (EMIR) and the CFTC’s derivatives rules in a number of key areas including clearing obligations, reporting obligations, segregation rules, collateral rules and margin requirements.

AIMA said in the paper that, if untreated, some of the conflicting rules may prevent counterparties from complying with either regime, leading to market fragmentation along geographical boundaries. AIMA said these effects could be mitigated for cross-border transactions by firms being allowed to follow the rules of the jurisdiction of one, rather than both counterparties to a transaction under a concept known as ‘substituted compliance’ in the US or ‘equivalence’ in the EU.

In the US and Europe, the CFTC, the US Securities and Exchange Commission and the European Commission, respectively, will soon determine the scope of their derivatives regulatory regime with respect to cross-border transactions. These decisions which will address the scope of substituted compliance and equivalence recognition will have a significant impact on the nature of the global derivatives market.

Andrew Baker, AIMA CEO, said: “AIMA strongly supports efforts to promote central clearing of OTC derivatives and to reduce systemic risk, and we appreciate the difficult task that regulators in each jurisdiction face in completing their separate OTC derivatives regulations in a prompt and thorough manner, while also ensuring that those regulations are, as far as possible, consistent with regulations being finalised and implemented by other regulatory authorities.

“However, we are concerned that OTC derivatives transactions could be subject to unnecessarily duplicative – or even conflicting – requirements as a result of extra-territorial application of domestic rules. The good news is that the regulatory authorities have the tools at their disposal to ensure we avoid market fragmentation and they are mindful of some of the potential negative consequences of uncoordinated action. We hope that, by highlighting the key examples of potential problems, our paper contributes to the current intensive international regulatory dialogue.”

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1